Pharmacologically targeting fatty acid synthase-mediated de novo lipogenesis alleviates osteolytic bone loss by directly inhibiting osteoclastogenesis through suppression of STAT3 palmitoylation and ROS signaling

Chunmei Xiu(Hangzhou City University), Jianquan Chen(Hangzhou City University), Guangxu He(Central South University), Chenxi Zhang(Hangzhou City University), Lei Zhang(Qingdao University), Xi Luo(Chinese Academy of Sciences), Kaizhong Ji(Hangzhou City University), Ziyi Zhang(Hangzhou City University), Yanxia Zhang(Hangzhou City University), Zhiyuan Chen(Wannan Medical College)
Metabolism
March 11, 2025
Cited by 15


Related Papers